Direct answer: Neither is an evidence-based winner for every goal. The clearest human comparison is narrower: small topical GHK-Cu studies examined photoaged skin, while one randomized study tested topical oxidized glutathione for skin outcomes. Those were separate studies with different designs, ingredients, and endpoints, so they do not show that one compound is better overall.
What the human GHK-Cu studies measured
A 2009 peer-reviewed review summarizes several short topical studies in women with photoaged skin. It describes facial and eye-area creams used twice daily for 12 weeks, with outcomes such as lines, wrinkles, skin appearance, density, and thickness. The underlying reports include 2002 conference abstracts and a later book chapter, rather than a published head-to-head trial against glutathione.
| Study group | Form and duration | Reported outcomes | Evidence source |
|---|---|---|---|
| 71 women with photodamage | Facial cream, twice daily for 12 weeks | Skin laxity, clarity, fine lines, wrinkles, density, and thickness | 2002 dermatology meeting abstract, summarized in the review |
| 41 women with photodamage | Eye-area cream, twice daily for 12 weeks | Lines, wrinkles, appearance, density, and thickness | 2002 dermatology meeting abstract, summarized in the review |
| 67 women aged 50 to 59 | Facial cream, twice daily for 12 weeks | Skin laxity, clarity, appearance, wrinkles, density, and thickness | Book chapter summarized in the review |
These findings concern topical creams and short-term skin measurements. They do not establish results for injected GHK-Cu, hair growth, wound treatment, or other uses.
What the glutathione skin study measured
Watanabe and colleagues studied oxidized glutathione (GSSG), not an injectable glutathione product. Thirty healthy women aged 30 to 50 took part in a randomized, double-blind, matched-pair study. Each woman applied 2% GSSG lotion to one side of the face and placebo lotion to the other, twice daily for 10 weeks.
| Face side | Starting mean | Week 10 mean | Change |
|---|---|---|---|
| 2% oxidized glutathione lotion | 272.77 | 243.47 | -29.30 |
| Placebo lotion | 274.13 | 265.50 | -8.63 |
The study reported a lower melanin index on the GSSG-treated side than the placebo side at week 10. This is one small study of one topical formulation and a measured skin outcome. It does not establish effects from reduced glutathione (GSH), oral supplements, injections, or liver and immune claims.
Why the studies cannot rank one compound above the other
The GHK-Cu reports and GSSG trial did not compare the two compounds directly. They used different formulations, participants, study designs, and outcome measures. A melanin-index result from a topical GSSG lotion cannot be compared numerically with wrinkle, skin-density, or appearance findings from separate GHK-Cu cream studies.
From the FormBlends catalog
GHK-Cu (Copper Peptide)
A copper peptide studied for skin and tissue support · From $179/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View GHK-Cu (Copper Peptide) →For a question specifically about topical skin research, the GSSG trial has a directly accessible randomized, double-blind report with a placebo comparison. The GHK-Cu findings summarized in the cited review include small studies whose underlying reports were conference abstracts or a book chapter. This describes the available reporting, not proof that one ingredient works better.
Frequently asked questions
Which has stronger human evidence?
It depends on the outcome and formulation. The cited glutathione study directly tested topical oxidized GSSG and measured skin outcomes in 30 women. The GHK-Cu review describes short topical studies in women with photoaged skin. Neither evidence set is a direct comparison, and neither supports a general ranking across skin, liver, immune, or injectable uses.
Did the studies test using both together?
No. The studies summarized here evaluated separate topical formulations. They do not establish combined-use effects or interactions.
Sources
- Gorouhi and Maibach, review of topical peptide studies, International Journal of Cosmetic Science, 2009
- Watanabe et al., topical oxidized glutathione randomized study, 2014
- Topically applied GHK as an anti-wrinkle peptide: review of the published evidence
Explore the Related Research
The linked guides compare other peptide pairings and the evidence behind each one.
Disclaimer: This article is for informational purposes only and doesn't constitute medical advice. Always consult with a licensed healthcare provider. Individual results may vary.
Ready when you are
GHK-Cu (Copper Peptide)
A copper peptide studied for skin and tissue support · From $179/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View GHK-Cu (Copper Peptide) →